Oncology - European Medical Journal

Continue

Oncology

Filter
13 Jun 2016

Helsinn Group Hosts a Satellite Symposium on Shared Decision Making in Supportive Care, at the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) Annual Meeting 2016 on June 24th

Lugano, Switzerland, June 13, 2016 – Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, today announces that it is…
2 Jun 2016

Helsinn Group to Present at ASCO Pooled Follow up Efficacy Data Analysis from Two Phase III Studies for Anamorelin in Cachectic Patients with Non-Small Cell Lung Cancer (NSCLC)

Lugano, Switzerland, June 1, 2016 – Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, today announces that it will present…
2 Jun 2016

Janssen’s IMBRUVICA®▼(Ibrutinib) Approved by European Commission for Patients with Newly Diagnosed Chronic Lymphocytic Leukaemia

Beerse/Belgium, 31 May, 2016 – Janssen-Cilag International NV (Janssen) announced today that the European Commission (EC) has approved IMBRUVICA®…
EMJ
31 May 2016

Promising Platelet Production Process Pioneered

MASS production of platelets is now one step closer, thanks to a team of researchers who have discovered a new method of creating platelet-producing…
EMJ
31 May 2016

Exercise Proves Key to Preventing Cancer

AN INTERNATIONAL team of researchers have compiled data from 12 different studies demonstrating the important role exercise can play in helping to…
EMJ
4 May 2016

Celyad announces oral presentation on NKR-2 T Cells Manufacturing for a First-in-Human Clinical Trial in AML and Multiple Myeloma

Mont-Saint-Guibert, Belgium – Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a leader in the discovery and development of engineered cell…
EMJ
29 Apr 2016

Glycotope Appoints Dr. Alfredo Zurlo as Chief Medical Officer

Berlin, Germany, April 29, 2016 – Glycotope GmbH, a clinical-stage immuno-oncology company built on world-leading glyco-biology expertise, today…
EMJ
21 Apr 2016

MammaPrint Genetic Test Can Reduce Use of Post-Surgery Chemotherapy among Early-Stage Breast Cancer Patients

NEW ORLEANS — Among patients with early-stage breast cancer who were considered at high risk for disease recurrence based on clinical and biological…
We’ve noticed you’re accessing
from North/South America.